MODIFICATION
A -- Pharmacokinetic & Pharmacodynamic Studies for Medications Development
- Notice Date
- 1/5/2017
- Notice Type
- Modification/Amendment
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 3155, MSC 9593, Bethesda, Maryland, 20892, United States
- ZIP Code
- 20892
- Solicitation Number
- HHS-NIH-NIDA-SBSS-17-004
- Point of Contact
- Christopher A. Weaver, Phone: (301) 443-6677, Andrew Hotaling, Phone: (301) 443-6677
- E-Mail Address
-
christopher.weaver@nih.gov, hotalingar@mail.nih.gov
(christopher.weaver@nih.gov, hotalingar@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- --- AMENDMENT --- The due date for written capability statements has been extended to NO LATER THAN 01/13/2017. Submit written capability statements to Christopher A. Weaver. Paper or electronic capability statements will be accepted.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-01/HHS-NIH-NIDA-SBSS-17-004/listing.html)
- Record
- SN04364978-W 20170107/170105235128-e63f32b79c113f63d7bd2af828cbb247 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |